Abstract
Background: Itch is a cardinal feature of paediatric disorders and can impair quality of life. However, few studies have addressed symptoms and impacts of itch in paediatric patients. Objectives: We focused on understanding the child’s experience of itch and the impact of itch specifically on affected children, including comparison with the adult experience. Methods: Semistructured interviews (nine parents, 15 children with itch) explored concerns related to paediatric itch experiences and effects. Themes were compared with those of previous adult interviews. Literature was reviewed to identify the need for a more comprehensive measure of paediatric itch. Results: Itch quality, intensity, duration and environmental triggers (sweating, climate change, stress and certain fabrics) are important aspects of the child’s itch experience. Skin disruption, physical function, concentration, emotional reactions, stigma and relationships/social effects are itch impact themes that emerged. No paediatric-specific scale comprehensively captures the paediatric patient itch experience. However, differences between child and adult reports of itch-related pain, functional limitations, fatigue and restlessness, emotional reactions to itch, and treatment effects emphasize the need for a paediatric-specific measurement tool. Conclusions: Children and parents endorse the importance of capturing the paediatric-focused characteristics and impacts of itch in measuring disease severity and response to intervention.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 896-904 |
| Number of pages | 9 |
| Journal | British Journal of Dermatology |
| Volume | 184 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2021 |
Funding
The authors thank the parents and children who participated in the interviews, Jayla Gray and Shalini Thareja for assisting in discussions and interviews, and Emily Lund, Sarah Chamlin and Anna Fishbein for providing expertise in paediatrics, paediatric dermatology and paediatric allergy, respectively, during the expert panel. The study was supported by a grant from the National Institutes of Health – National Institute of Arthritis and Musculoskeletal and Skin Diseases (U19 069526) and the Northwestern University Clinical and Translational Sciences Institute (UL1TR001422). This study was funded by the National Institutes of Health – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH NIAMS) (U19069526) and the Northwestern University Clinical and Translational Sciences Institute (NUCATS) (UL1TR001422). The funders were not involved in study design, data collection, data analysis, manuscript preparation and/or publication decisions.
ASJC Scopus subject areas
- Dermatology